Navigation Links
Metavante Corp. will continue M&A activity

Milwaukee, Wis. Metavante Corp., a provider of banking and payment technology, plans to continue its growth-by-acquisition strategy following its separation from long-time parent company Marshall & Illsley Corp.

Metavante, a wholly owned subsidiary of M&I, has completed 17 acquisitions since early 2004, all......

Full article >>> enue of $1.5 billion and had net income of $160 million in 2006, and it will have 5,500 employees at the close of the transaction. A total of 980 financial institution clients, with aggregate assets exceeding $1 trillion, are served by its core payment processing platform, and it also has one of the nation's largest electronic bill-paying platforms.

During his address to investors, Marti......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 04/04/07


Related biology technology :

1. Metavante fires 180 North American workers
2. Metavante forms cash-management division
3. Metavante broker technology licensed to ING Bank
4. Metavante to buy California software developer
5. Metavante application aimed at compliance
6. CIO Leadership Series: Brian Hurdis, Metavante
7. Metavante expands healthcare payments division
8. Metavante acquires health-care payments firm
9. M & Is Metavante completes Brasfield Corp. acquisition
10. Metavante acquiring LINK2Gov
11. Metavante completes GHR Systems acquisition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  OncoSec Medical ... cancer immunotherapies, will host a Key Opinion Leader event ... as an oral and poster presentation at the upcoming ... plan. The KOL event will be held in-person and ... PM EST / 9:00 AM PST at the Lotte ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
Breaking Biology Technology:
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):